Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 171-178

  Urshansky, Nataly ^a   Mausner Fainberg, Karin ^a,b   Auriel, Eitan ^a,b   Regev, Keren ^a   Bornstein, Natan M ^a,b   Karni, Arnon ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Multiple sclerosis; Neurogenesis; Noggin; T cells

Indexed keywords

CD28 ANTIGEN; CD3 ANTIBODY; MESSENGER RNA; NOGGIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL INFILTRATION; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; T LYMPHOCYTE; UPREGULATION;

ADULT; BLOTTING, WESTERN; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79952248850     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.10.007     Document Type: Article

References (65)

1. Antel J.P., Freedman M.S., Brodovsky S., Francis G.S., Duquette P. Activated suppressor cell function in severely disabled patients with multiple sclerosis. Ann. Neurol. 1989, 25:204-207.
2. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
3. Arnon R., Aharoni R. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. J. Neural Transm. 2009, 116:1443-1449.
4. Astier A.L., Meiffren G., Freeman S., Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 2006, 116:3252-3257.
5. Azoulay D., Vachapova V., Shihman B., Miler A., Karni A. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate. J. Neuroimmunol. 2005, 167:215-218.
6. Azoulay D., Urshansky N., Karni A. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J. Neuroimmunol. 2008, 195:186-193.
7. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo B.F., Rao M.S., Sherman L.S. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 2005, 11:966-972.
8. Balashov K.E., Khoury S.J., Hafler D.A., Weiner H.L. Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J. Clin. Invest. 1995, 95:2711-2719.
9. Balashov K.E., Smith D.R., Khoury S.J., Hafler D.A., Weiner H.L. Increased IL-12 production in progressive multiple sclerosis: induction by activated CD4+ T-cells via CD40 ligand. Proc. Natl Acad. Sci. USA 1997, 94:599-603.
10. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl Acad. Sci. USA 1999, 96:6873-6878.
11. Barnet M.H., Prineas J.W. Relapsing and remitting multiple sclerosis; pathology of newly forming lesion. Ann. Neurol. 2004, 55:458-468.
12. Bieber A.J., Kerr S., Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann. Neurol. 2003, 53:680-684.
13. Bomstein Y., Marder J.B., Vitner K., Smirnov I., Lisaey G., Butovsky O., Fulga V., Yoles E. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J. Neuroimmunol. 2003, 142:10-16.
14. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A.E., Pluchino S., Martino G., Schwartz M. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 2006, 31:149-160.
15. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J. Med. 2002, 346:165-173.
16. Charles P., Reynolds R., Seilhean D., Rougon G., Aigrot M.S., Niezgoda A., Zalc B., Lubetzki C. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor or remyelination in multiple sclerosis?. Brain 2002, 125:1972-1979.
17. Ferguson B., Matyszak M.K., Esiri M.M., Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120:393-399.
18. Foote A.K., Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 2005, 128:528-539.
19. Franklin R.M., Ffrench-Constant C. Remyelination in CNS: from biology to therapy. Nat. Neurosci. 2008, 9:839-855.
20. Frohman E.M., RackeM K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N Engl J. Med. 2006, 354:942-955.
21. Groppe J., Greenwald J., Wiater E., Rodriguez-Leon J., Economidesk A.N., Kwiatkowski W., Affolter M., Vale W.W., Izpisua Belmonte J.C., Choe Senyon Structural basis of BMP signaling inhibition by cystine knot protein Noggin. Nature 2002, 420:636-642.
22. Hauben E., Gothilf A., Cohen A., Butovsky O., Nevo U., Smirnov I., Yoles E., Akselrod S., Schwartz M. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J. Neurosci. 2003, 23:8808-8819.
23. Hermann-Kleiter N., Baier G. NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 2010, 115:2989-2997.
24. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 2000, 107:161-166.
25. Hohlfeld R., Kerschensteiner M., Meinl E. Dual role of inflammation in CNS disease. Neurology 2007, 68:58-63.
26. Itsykson P., Ilouz N., Turetsky T., Goldstein R.S., Pera M.F., Fishbein I., Segal M., John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 2002, 8:1115-1121.
27. Karni A., Balashov K., Hancock W.W., Bharanidharan P., Abraham M., Khoury S.J., Weiner H.L. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis. J. Neuroimmunol. 2004, 146:189-198.
28. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., Khoury S.J., Weiner H.L. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 2006, 177:4196-4202.
29. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 1999, 189:865-870.
30. Kondo T., Raff M.C. A role for Noggin in the development of oligodendrocyte precursor cells. Dev. Biol. 2004, 267:242-251.
31. Kotter M.R., Zhao C., van Rooijen N., Franklin R.J.M. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 2005, 18:166-175.
32. Kotter M.R., Li W.W., Zhao C., Franklin R. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 2006, 26:328-332.
33. Kuhlmann T., Miron V., Cuo Q., Wegner C., Antel J., Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008, 131:1749-1758.
34. Lassman H. What drives disease in multiple sclerosis: inflammation or neurodegeneration?. Clin. Exp. Neuroimmunol. 2010, 1:2-11.
35. Lim D.A., Tramontin A.D., Trevejo J.M., Herrera D.G., García-Verdugo J.M., Alvarez- Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 2000, 28:713-726.
36. Lubetzki C., Williams A., Stankoff B. Promoting repair in multiple sclerosis: problems and prospects. Curr. Opin. Neurol. 2005, 18:237-244.
37. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996, 4:907-911.
38. Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
39. Ludwin S.K. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies. J. Neuropathol. Exp. Neurol. 2006, 65:305-318.
40. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 1992, 10:153-187.
41. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005, 8:745-751.
42. Mikami Y., Okano H., Sakaguchi M., Nakamura M., Shimazaki T., Okano H.J., Kawakami Y., Toyama Y., Toda M. Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. J. Neurosci. Res. 2004, 76:453-465.
43. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 1999, 5:49-55.
44. Patani R., Balaratnam M., Vora A., Reynolds R. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol. Appl. Neurobiol. 2007, 33:277-287.
45. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Brück W., Lucchinetti C., Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172.
46. Picard-Riera N., Decker L., Delarasse C., Nait-Oumesmar B., Liblau R., Pham-Dinh D., Evercooren A.B. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc. Natl Acad. Sci. 2002, 99:13211-13216.
47. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
48. Pluchino S., Zanotti L., Brambilla E., Rovere-Querini P., Capobianco A., Alfaro-Cervello C., Salani G., Cossetti C., Borsellino G., Battistini L., Ponzoni M., Doglioni C., Garcia-Verdugo J.M., Comi G., Manfredi A.A., Martino G. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS ONE 2009, 4:e5959.
49. Raine C.S., Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 1993, 52:199-204.
50. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 1998, 4:814-821.
51. Reinhold M.I., Abe M., Kapadia R.M., Liao Z., Naski M.C.J. FGF18 represses noggin expression and is induced by calcineurin. Biol. Chem. 2004, 279:38209-38219.
52. Sarchielli P., Zaffaroni M., Floridi A., Greco L., Candeliere A., Mattioni A., Tenaglia S., Di Filippo M., Calabresi P. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins. Mult. Scler. 2007, 13:313-331.
53. Schwartz M., Cohen J.R. Autoimmunity can benefit self-maintenance. Immunol. Today 2000, 21:265-268.
54. Schwartz M., Moalem G., Leibowitz-Amit R., Cohen I.R. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 1999, 22:295-299.
55. δE9 transgenic mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2009, 385:341-345.
56. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247-269.
57. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mörk S., Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J. Med. 1998, 338:278-285.
58. Urshansky N., Mausner-Fainberg K., Auriel E., Regev K., Farhum F., Karni A. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis. J. Neurol. Sci. 2010, 295:31-37.
59. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
60. Vargas M.E., Barres B.A. Why is Wallerian degeneration in the CNS so slow?. Annu. Rev. Neurosci. 2007, 30:153-179.
61. Viglietta V., Baecher-Allan C., Weiner H.L., Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
62. Weinshenker B.G., Ebers G.C. The natural history of multiple sclerosis. Can. J. Neurol. Sci. 1987, 3:255-261.
63. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 1998, 18:601-609.
64. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002, 125:338-349.
65. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., Cohen H., Kipnis J., Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatlearning abilities in adulthood. Nat. Neurosci. 2006, 9:268-27.